CD8A and non-small cell lung carcinoma: To better explore the prognostic value of CD4+TIL and CD8+TIL in patients with NCT‐NSCLC, the CD4+/CD8+TIL ratio and change in CD4+TIL and CD8+TIL levels were analyzed using Kaplan–Meier survival analysis.